Assessment of Restored Kidney Transplantation Including the Use of Wider Criteria for Accepting Renal Donors After Cancer Excision

Por Philip Sprott, FRACS, Adrian D. Hibberd, MD, Munish K. Heer, MS, Paul R. Trevillian, FRACP, David A. Clark, CertPath, David W. Johnson, FRACP, Christopher Oldmeadow, PhD, Simon Chiu, PGDipAppStat, John R. Attia, MD
Publicado em 2019-11-01

Decreased expression of EphA5 is associated with Fuhrman nuclear grade and pathological tumour stage in ccRCC

Por Wang, Xiaolin, Xu, Haifei, Wu, Zhijun, Chen, Xiao, Wang, Jiandong
Publicado no Int J Exp Pathol (2017)

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

Por Shaw, D M, Connolly, N B, Patel, P M, Kilany, S, Hedlund, G, Nordle, Ö, Forsberg, G, Zweit, J, Stern, P L, Hawkins, R E
Publicado em 2007

Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis

Por Min-Che Tung, Yung-Wei Lin, Wei-Jiunn Lee, Yu-Ching Wen, Yu-Cheng Liu, Ji-Qing Chen, Michael Hsiao, Yi-Chieh Yang, Ming-Hsien Chien
Publicado em 2022-04-01

Minimally invasive tumor therapies

Por Stroszczynski, C.
Publicado em 2006

Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic Renal Cell Carcinoma

Por Kwiatkowski, David J., Choueiri, Toni K., Fay, André P., Rini, Brian I., Thorner, Aaron R., de Velasco, Guillermo, Tyburczy, Magdalena E., Hamieh, Lana, Albiges, Laurence, Agarwal, Neeraj, Ho, Thai H., Song, Jiaxi, Pignon, Jean-Christophe, Barrios, Pablo M., Michaelson, M. Dror, Van Allen, Eliezer, Krajewski, Katherine M., Porta, Camillo, Pal, Sumanta, Bellmunt, Joaquim, McDermott, David F., Heng, Daniel Y. C., Gray, Kathryn P., Signoretti, Sabina
Publicado no Clin Cancer Res (2016)

Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B.

Por Solomkin, J S, Flohr, A, Simmons, R L
Publicado em 1982

Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting(1)(2)(3)(4)

Por Gullett, Norleena P, Hebbar, Gautam, Ziegler, Thomas R
Publicado em 2010

A phase II trial of the nucleolin-targeted DNA aptamer AS1411 in metastatic refractory renal cell carcinoma

Por Rosenberg, Jonathan E., Bambury, Richard, Drabkin, Harry A., Lara, Primo N., Harzstark, Andrea L., Figlin, Robert A., Smith, Gregory W., Choueiri, Toni, Erlandsson, Fredrik, Laber, Damian A.
Publicado no Invest New Drugs (2013)

Increased Cancer Risks in Myotonic Dystrophy

Por Win, Aung Ko, Perattur, Promilla G., Pulido, Jose S., Pulido, Christine M., Lindor, Noralane M.
Publicado em 2012

N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats

Por Chen, N, Aleksa, K, Woodland, C, Rieder, M, Koren, G
Publicado em 2008

Phase II Trial Of Neoadjuvant Axitinib In Patients With Locally Advanced Non-Metastatic Clear Cell Renal Cell Carcinoma

Por Karam, Jose A., Devine, Catherine E., Urbauer, Diana L., Lozano, Marisa, Maity, Tapati, Ahrar, Kamran, Tamboli, Pheroze, Tannir, Nizar M., Wood, Christopher G.
Publicado no Eur Urol (2014)

Specific immunotherapy in renal cancer: a systematic review

Por Armin Hirbod-Mobarakeh, Hesam Addin Gordan, Zahra Zahiri, Mohammad Mirshahvalad, Sima Hosseinverdi, Brian I. Rini, Nima Rezaei
Publicado em 2017-02-01

Malignant Rhabdoid Tumors Originating Within and Outside the Central Nervous System Are Clinically and Molecularly Heterogeneous

Por Pinto, Emilia M., Hamideh, Dima, Bahrami, Armita, Orr, Brent A., Lin, Tong, Pounds, Stanley, Zambetti, Gerard P., Pappo, Alberto S., Gajjar, Amar, Agnihotri, Sameer, Broniscer, Alberto
Publicado no Acta Neuropathol (2018)

Persistence of Human Papillomavirus DNA in Benign and (Pre)malignant Skin Lesions from Renal Transplant Recipients

Por Berkhout, Ron J. M., Bouwes Bavinck, Jan N., ter Schegget, Jan
Publicado em 2000

Image Processing and Analysis for Preclinical and Clinical Applications

Publicado em 2022

Five-year overall survival of metastatic renal cell carcinoma patients treated with everolimus...

Por S. Z. Safina, S. A. Varlamov, A. V. Snegovoy, I. S. Varlamov, L. I. Gurina, L. V. Manzuk, I. V. Tsimafeyeu
Publicado em 2017-12-01

Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers

Por Geller, Melissa A., Cooley, Sarah, Argenta, Peter A., Downs, Levi S., Carson, Linda F., Judson, Patricia L., Ghebre, Rahel, Weigel, Brenda, Panoskaltsis-Mortari, Angela, Curtsinger, Julie, Miller, Jeffrey S.
Publicado em 2010

Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study

Por Donato, Jessica, Campigotto, Federico, Uhlmann, Erik J., Coletti, Erika, Neuberg, Donna, Weber, Griffin M., Zwicker, Jeffrey I.
Publicado no Blood (2015)

Clinical Features and Long-Term Outcomes of Systemic Lupus Erythematosus

Publicado em 2023